Correlation Between Medexus Pharmaceuticals and Cipher Pharmaceuticals

Can any of the company-specific risk be diversified away by investing in both Medexus Pharmaceuticals and Cipher Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Medexus Pharmaceuticals and Cipher Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Medexus Pharmaceuticals and Cipher Pharmaceuticals, you can compare the effects of market volatilities on Medexus Pharmaceuticals and Cipher Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Medexus Pharmaceuticals with a short position of Cipher Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Medexus Pharmaceuticals and Cipher Pharmaceuticals.

Diversification Opportunities for Medexus Pharmaceuticals and Cipher Pharmaceuticals

0.01

Correlation Coefficient

Medexus Pharmaceuticals  Cipher Pharmaceuticals

Significant diversification

The 3 months correlation between Medexus and Cipher is 0.01. Overlapping area represents the amount of risk that can be diversified away by holding Medexus Pharmaceuticals and Cipher Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Cipher Pharmaceuticals and Medexus Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Medexus Pharmaceuticals are associated (or correlated) with Cipher Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Cipher Pharmaceuticals has no effect on the direction of Medexus Pharmaceuticals i.e., Medexus Pharmaceuticals and Cipher Pharmaceuticals go up and down completely randomly.

Pair Corralation between Medexus Pharmaceuticals and Cipher Pharmaceuticals

Assuming the 90 days trading horizon Medexus Pharmaceuticals is expected to generate 1.51 times more return on investment than Cipher Pharmaceuticals. However, Medexus Pharmaceuticals is 1.51 times more volatile than Cipher Pharmaceuticals. It trades about 0.02 of its potential returns per unit of risk. Cipher Pharmaceuticals is currently generating about -0.09 per unit of risk. If you would invest  280.00  in Medexus Pharmaceuticals on May 1, 2025 and sell it today you would earn a total of  0.00  from holding Medexus Pharmaceuticals or generate 0.0% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Insignificant
Accuracy	100.0%
Values	Daily Returns

Medexus Pharmaceuticals  vs.  Cipher Pharmaceuticals

Medexus Pharmaceuticals

Risk-Adjusted Performance

Insignificant

Compared to the overall equity markets, risk-adjusted returns on investments in Medexus Pharmaceuticals are ranked lower than 1 (%) of all global equities and portfolios over the last 90 days. In spite of very healthy basic indicators, Medexus Pharmaceuticals is not utilizing all of its potentials. The recent stock price disarray, may contribute to short-term losses for the investors.

Cipher Pharmaceuticals

Risk-Adjusted Performance

Very Weak

Over the last 90 days Cipher Pharmaceuticals has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest abnormal performance, the Stock's technical indicators remain healthy and the recent disarray on Wall Street may also be a sign of long period gains for the firm investors.

Pair Trading with Medexus Pharmaceuticals and Cipher Pharmaceuticals

The main advantage of trading using opposite Medexus Pharmaceuticals and Cipher Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Medexus Pharmaceuticals position performs unexpectedly, Cipher Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Cipher Pharmaceuticals will offset losses from the drop in Cipher Pharmaceuticals' long position.

The idea behind Medexus Pharmaceuticals and Cipher Pharmaceuticals pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Bonds Directory module to find actively traded corporate debentures issued by US companies.